A5037346707- Opioid Use Disorder Treatment
- Pharmaceutical Practices and Patient Outcomes
- Substance Abuse Treatment and Outcomes
- HIV, Drug Use, Sexual Risk
- Poisoning and overdose treatments
- Pain Management and Opioid Use
- Pharmaceutical studies and practices
- Prenatal Substance Exposure Effects
- Medication Adherence and Compliance
- Health Policy Implementation Science
- Emergency and Acute Care Studies
- Antibiotic Use and Resistance
- Pharmaceutical Economics and Policy
- Blood Pressure and Hypertension Studies
- Forensic Toxicology and Drug Analysis
- Health Systems, Economic Evaluations, Quality of Life
- Healthcare Policy and Management
- Pharmacogenetics and Drug Metabolism
- Economic and Environmental Valuation
- HIV/AIDS Research and Interventions
- Vaccine Coverage and Hesitancy
- Musculoskeletal pain and rehabilitation
- Pharmacology and Obesity Treatment
- Patient Satisfaction in Healthcare
- Nursing Roles and Practices
University of Kentucky
2015-2025
Poliomyelitis Research Foundation
2024
Delaware County Memorial Hospital
2024
University of Cincinnati
2024
Boston College
2022-2023
The University of Texas at Austin
2022
Brandeis University
2022
National Bureau of Economic Research
2020
University of Indianapolis
2020
Indiana University – Purdue University Indianapolis
2020
Concern exists that hypothetical willingness to pay questions overestimate real pay. In a field experiment, we compare two methods of removing bias, cheap talk approach and certainty approach, with purchases. We find evidence bias for unadulterated contingent valuation. Contingent valuation statements removes the but has no significant impact. Our findings suggest can be accurately estimated by adding simple follow‐up question about responses is not generally effective approach.
Opioid overdose deaths remain high in the U.S. Despite having effective interventions to prevent deaths, there are numerous barriers that impede their adoption. The primary aim of HEALing Communities Study (HCS) is determine impact an intervention consisting community-engaged, data-driven selection, and implementation integrated set evidence-based practices (EBPs) on reducing opioid deaths.The HCS a four year multi-site, parallel-group, cluster randomized wait-list controlled trial. (n = 67)...
The number of opioid-involved overdose deaths in the United States remains a national crisis. HEALing Communities Study (HCS) will test whether That HEAL (CTH), community-engaged intervention, can decrease intervention communities (n = 33), relative to wait-list 34), from four states. CTH seeks facilitate widespread implementation three evidence-based practices (EBPs) with potential reduce fatalities: education and naloxone distribution (OEND), effective delivery medication for opioid use...
To mitigate the opioid overdose crisis, states have implemented a variety of legal interventions aimed at increasing access to antagonist naloxone. Recently, Virginia and Vermont mandated coprescription naloxone for potentially at-risk patients.To assess association between mandates dispensing in retail pharmacies.This was population-based, state-level cohort study. The sample included all prescriptions dispensed pharmacy setting contained IQVIA's national prescription audit, which...
The implementation of evidence-based practices to reduce opioid overdose deaths within communities remains suboptimal. Community engagement can improve the uptake and sustainability practices. HEALing Communities Study (HCS) aims through That HEAL (CTH) intervention, a community-engaged, data-driven planning process that will be implemented in 67 across four states. An iterative was used development community component CTH. resulting uses phased steeped principles based participatory...
BACKGROUND: Gabapentin is prescribed for a variety of conditions and often used off label. It important to understand the prevalence gabapentin prescribing characteristics individuals who are gabapentin, given increasing concern regarding its potential misuse. OBJECTIVES: To (a) examine state- region-level trends in from 2009 2016 (b) characterize demographic clinical nationwide population commercially insured adults. METHODS: This retrospective, longitudinal study examined 2016. The...
Interview with Dr. Justin Berk on starting patients recently released from incarceration treatment for opioid use disorder. (10:59)Download Federal and state initiatives designed to increase access buprenorphine have focused nearly exclusively physicians other prescribers. Yet their success depends entirely whether pharmacists dispense who present a prescription.
Background: Concerns have been raised that pharmacists sometimes act as barriers to patients with opioid use disorder (OUD) accessing buprenorphine treatment. The present research explores how community pharmacists’ endorsement (vs non-endorsement) of stigmatizing beliefs about taking relate intentions, comfort, and decisions regarding dispensing for OUD. In addition, we assessed attitudes toward risk in pharmacy practice a novel correlate intentions decisions. Methods: A sample 207 active...
Opioid overdoses differentially affect demographic groups. Strategies to reduce overdose deaths, specifically education and naloxone distribution (OEND), are not consistently delivered equitably.
Opioid-involved overdose deaths continue to surge in many communities, despite numerous evidence-based practices (EBPs) that exist prevent them. The HEALing Communities Study (HCS) was launched develop and test an intervention (ie, That HEAL (CTH)) supports communities expanding uptake of EBPs reduce opioid-involved deaths. This paper describes a protocol for process foundational the CTH through which community coalitions select strategies implement locally.
Objective Buprenorphine is a medication for opioid use disorder that reduces mortality. This study aims to investigate the less well-understood relationship between dose in early stages of treatment and subsequent risk death. Methods We used Kentucky prescription monitoring data identify adult residents initiating transmucosal buprenorphine (January 2017 November 2019). Average daily days covered first 30 was categorized as ≤8 mg, >8 ≤16 >16 mg. Patients were followed 365 after...
Abstract Background People incarcerated in jails are highly impacted by the opioid epidemic, and overdose education naloxone distribution (OEND) is an effective strategy to reduce deaths. This study examines barriers facilitators of fast-track OEND implementation within Wave 1 Kentucky counties HEALing Communities Study during COVID-19 pandemic. Methods Meeting minutes with jail stakeholders were qualitatively coded using Practical, Robust Implementation Sustainability Model (PRISM) as...
Abstract Background Efforts to scale up overdose education and naloxone distribution (OEND), an evidence-based practice for reducing opioid mortality, was a major focus of the HEALing Communities Study (HCS). The aim this analysis is describe qualitative perspectives partner organizations regarding impacts implementing OEND in state that used “hub with many spokes” model scaling strategy. Methods Small group ( n = 20) individual 24) interviews were conducted staff from 44 agencies eight...
Abstract Purpose Increased opioid analgesic prescribing (OAP) has been associated with increased risk of prescription diversion, misuse, and abuse. We studied regional rural‐urban variations in OAP trends Kentucky, from 2012 to 2015, examined potential county‐level protective factors. Methods This study used drug monitoring data. Marginal models employing generalized estimating equations were model repeated counts residents prescriptions within county‐quarter, 2012–2015, offset for resident...